Microvesicles and epithelial mesenchymal transition in the development of cancer by Inal, Jameel
Microvesicles and epithelial mesenchymal transition in the 
development of cancer
Ahmad zia Haidery and Jameel M. Inal
London Metropolitan University, London, United Kingdom
Microvesicles released by tumour cell lines are thought to play 
an important role in both extracellular matrix (ECM) invasion and 
evasion of the immune system. We have examined the role of 
MVs derived from a T cell line (Jurkat) on PNT2 cells (normal 
prostate cells) to see if they carry some bioactive molecules 
capable of inducing an epithelial to mesenchymal transition (EMT) 
in normal prostate cells. The link between EMT and malignancy 
has been well documented in almost all carcinomas of epithelial 
origin. However, to understand the mechanism by which MVs 
may induce this and to show the factors carried by MVs, further 
tests including invasion assays, angiogenesis and apoptotic 
assays as well as proteomic analyses will be needed. By micro-
scopic analysis, PNT2 cells, which are of epithelial origin, treated 
with Jurkat MVs, showed some morphological changes. They 
become elongated, motile and morphologically mesenchymal-
like as previously documented. The molecular changes were 
confirmed by immunohistochemical techniques using the 
fluorescencent microscope and flow cytometer. The experi-
mental (MV-treated cells) compared to control (untreated cells) 
expressed high levels of mesenchymal markers such as Vimentin 
and low levels of epithelial markers such as E-Cadherin. Proteins 
from PNT2 control cells and MV- treated cells were profiled by 
SDS- PAGE, MV-treated cells showing a band around 13 kDa, 
which is currently being identified by mass spectrometry. 
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